Caspofungin Acetate NDC 63323-356

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-356Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0356Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63323-356-10	63323035610	10 VIAL, SINGLE-DOSE in 1 CARTON (63323-356-10) / 10.8 mL in 1 VIAL, SINGLE-DOSE (63323-356-01)Marketed from Dec 30, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Caspofungin Acetate
Generic name (nonproprietary): caspofungin acetate
Active ingredients: Caspofungin acetate — 5 mg/mL
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intravenous
Labeler: Fresenius Kabi USA, LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 206110
Marketing start: Dec 30, 2016
Listing expires: Dec 31, 2027
Other FDA classes: Lipopeptides (Chemical structure)
Identifiers: Product ID 63323-356_7cdf103b-418f-42a8-bd1b-ebfd8027124aSPL ID 7cdf103b-418f-42a8-bd1b-ebfd8027124aSPL set ID e76d8d83-3691-451c-a32c-d91448c54d16RxCUI 828539, 828755UNII VUW370O5QE
Pharmacologic class: Echinocandin Antifungal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463323035610 followed by a unit qualifier and the quantity

Package 63323-0356-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 8, 2026.

Indications (excerpt from the label)

Caspofungin acetate for Injection is an echinocandin antifungal indicated in adults and pediatric patients (3 months of age and older) for: • Empirical therapy for presumed fungal infections in febrile, neutropenic patients. ( 1 ) • Treatment of candidemia and the following Candida infections: intra-abdominal abscesses, peritonitis and pleural space infections. ( 1 ) • Treatment of esophageal candidiasis. ( 1 ) • Treatment of invasive aspergillosis in patients who are refractory to or intolerant of other therapies. ( 1 ) 1.1 Empirical Therapy for Presumed Fungal Infections in Febrile, Neutropenic Patients Caspofungin acetate for Injection is indicated as empirical therapy for presumed fungal…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 206110

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 206110
Product	Strength	Form · route	Labeler	Product NDC
Caspofungin Acetate	Caspofungin acetate 7 mg/mL	Injection, Powder, Lyophilized, For solutionIntravenous	Fresenius Kabi USA, LLC	63323-358